Skip to main content
. 2023 Jan 19;47(2):232–241. doi: 10.4093/dmj.2021.0355

Fig. 1.

Fig. 1.

Prevalence of sarcopenia in study participants, grouped according to the presence of hepatic steatosis. (A) Sarcopeniaweight was defined as skeletal muscle mass index (SMI, %) <2 standard deviations below the gender-specific mean for healthy young adults in the Korean population: SMI (%) <29.0 in men and <22.9 in women was considered as sarcopenia. (B) Sarcopeniaheight was defined as an appendicular skeletal mass/height2 ratio <7.0 in men and <5.7 in women. NAFLD, non-alcoholic fatty liver disease.